Mycobacterium research and diagnosis
Mycobacterium research and diagnosis is a research topic within Epidemiology. Science Explorer counts 50k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, treatment, and epidemiology of nontuberculous mycobacterial diseases, with a particular emphasis on Mycobacterium avium and Mycobacterium abscessus. It covers topics such as the impact of genotypic studies, antibiotic resistance, prevalence in specific patient populations (e.g., Crohn's disease, cystic fibrosis), and environmental sources. The cluster also delves into genomic and comparative genomic studies supporting the division of the genus Mycobacterium.
- Nontuberculous Mycobacteria
- Mycobacterium avium
- Mycobacterium abscessus
- Epidemiology
- Diagnosis
- Treatment
- Genomic Studies
- Crohn's Disease
- Cystic Fibrosis
- Antibiotic Resistance
- Research works
- 50k fractional, since 1950
- In the world top 10%
- 5.1k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -4% the tick is no change
- Largest producer
United States
30% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Mycobacterium research and diagnosis research?
By volume, the United States and China publish the most (1.5k and 1.2k works in 2022-now).
By volume, 2022-now
- 1
United States 1.5k works
- 2
China 1.2k works
- 3
India 696 works
- 4
Japan 391 works
- 5
United Kingdom 285 works
- 6
Brazil 279 works
- 7
South Korea 217 works
- 8
France 213 works
- 9
Spain 185 works
- 10
Germany 182 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Mycobacterium research and diagnosis research?
By volume in 2022-now, Capital Medical University publishes the most Mycobacterium research and diagnosis research, followed by Harvard University and All India Institute of Medical Sciences.
By volume, 2022-now
- 1
Capital Medical University
China 54 works
- 2
Harvard University
United States 42 works
- 3
All India Institute of Medical Sciences
India 42 works
- 4
Russian Academy of Sciences
Russia 40 works
- 5
Zhejiang University
China 37 works
- 6
Centre National de la Recherche Scientifique
France 34 works
- 7
Sichuan University
China 33 works
- 8
National Institutes of Health
United States 32 works
- 9
Chinese Academy of Medical Sciences & Peking Union Medical College
China 31 works
- 10
Fudan University
China 31 works
Who are the leading researchers in Mycobacterium research and diagnosis?
The most-cited researchers publishing on Mycobacterium research and diagnosis include Eric S. Lander, Rob Knight and Mark J. Daly.
- 1
Eric S. Lander
United States 524k citations
- 2
Rob Knight
United States 468k citations
- 3
Mark J. Daly
United States 403k citations
- 4
Peer Bork
Germany 396k citations
- 5
Guido Kroemer
France 386k citations
- 6
Steven L. Salzberg
United States 372k citations
- 7
Hermann Brenner
Germany 343k citations
- 8
Shizuo Akira
Japan 342k citations
- 9
Jun Wang
China 340k citations
- 10
Matthias Egger
Switzerland 326k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Mycobacterium research and diagnosis research done?
The largest centres of Mycobacterium research and diagnosis research in 2022-now are Beijing (China), Tokyo (Japan), Shanghai (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Denver and Cape Town.
Largest cities, 2022-now
Where it is the local speciality
- DenverUS · 38.5 works8.0×
- Cape TownZA · 22.9 works7.5×
Location quotient: how much more of its research is in Mycobacterium research and diagnosis than the world average.
Where is the best place to study Mycobacterium research and diagnosis?
Among universities, judged by research, Harvard University, University of Pittsburgh and Capital Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Mycobacterium research and diagnosis, country by countryIs Mycobacterium research and diagnosis research growing?
Output in 2022-2025 was 4% lower than in 2018-2021, peaking in 2019.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Mycobacterium research and diagnosis as a percentage of every work published that year, 0.033% in 2024.
Fractional works of Mycobacterium research and diagnosis over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Mycobacterium research and diagnosis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.